PROCEPT BioRobotics (NASDAQ:PRCT) reported quarterly losses of $(0.56) per share which met the analyst consensus estimate. This is a 24.44 percent decrease over losses of $(0.45) per share from the same period last year. The company reported quarterly sales of $83.132 million which beat the analyst consensus estimate of $80.506 million by 3.26 percent. This is a 20.20 percent increase over sales of $69.162 million the same period last year.